3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company: Evommune, Inc.
Filed: November 5, 2025
Period of Report: November 5, 2025
Accession Number: 0001012975-25-000705

View Document ↗ View on SEC.gov ↗